Latin America Balloon Catheters Market Report and Forecast 2024-2032

Latin America Balloon Catheters Market Size

The global balloon catheters market was valued at USD 4.5 billion in 2023, with Latin America holding a significant market share. The market is driven by the rising prevalence of cardiovascular diseases and the growing demand for minimally invasive procedures. It is expected to grow at a CAGR of 6.5% during the forecast period of 2024-2032, with the values likely to attain USD 4.8 billion by 2032.

Latin America Balloon Catheters Market Outlook

• In September 2023, Endovastec’s Reewarm ™ PTX Drug Coated Balloon (DCB) Catheter was implanted for the first time in Brazil in a popliteal artery stenosis patient and showed positive post-operative results. The rising introduction of such innovative balloon catheter devices is poised to elevate the Latin America balloon catheters market value.

• The rising patient inclination towards minimally invasive interventional surgeries, due to their advantages over traditional surgical approaches, is expected to boost the market share.

• Recent data reveals that cardiovascular disease is the leading cause of death in South America, accounting for 31% of all cases. This rising burden of cardiovascular conditions is likely to augment the market demand for balloon catheters.

Latin America Balloon Catheters Market Analysis

Balloon catheters are medical devices with a range of therapeutic and diagnostic applications such as expanding blocked or narrowed vessels and stent placement. It consists of a long, flexible tube with a small inflatable balloon at its tip. These specialized devices offer a minimally invasive treatment option as compared to traditional surgery, requiring only small incisions, and causing minimal impact on the surrounding tissues. The rising patient inclination towards minimally invasive procedures is expected to propel the Latin America balloon catheters market growth.

The market is also influenced by the increasing prevalence of cardiovascular diseases, leading to higher demand for diagnostic and interventional cardiology procedures, including those requiring balloon catheters. Recent data reveals that cardiovascular disease is the leading cause of death in South America, accounting for 31% of all cases, which can be attributed primarily to high blood pressure, tobacco use, obesity, and diabetes.  This rising burden of cardiovascular conditions is likely to augment the market demand for balloon catheters.

One of the major Latin America balloon catheters market trends is the increased adoption of advanced balloon catheters in cardiovascular treatments. In September 2023, Reewarm ™ PTX Drug Coated Balloon (DCB) Catheter was implanted for the first time in Brazil in a popliteal artery stenosis patient. The catheter, developed by a global medical device Endovastec™, showed positive post-operative results with clear blood flow in the popliteal artery, recovered lower limb blood circulation, and reduced symptoms of arterial ischemia. The rising introduction of such innovative balloon catheter devices is poised to improve patient outcomes and elevate the market value in the region.

Latin America Balloon Catheters Market Segmentation

The report offers a detailed analysis of the market based on the following segments:

Leading Players in the Latin America Balloon Catheters Market

The key features of the market report include patent analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• Abbott Laboratories

• Becton Dickinson and Company

• Boston Scientific Corporation

• Bard Medical Division

• B. Braun Melsungen AG

• Johnson & Johnson

• Teleflex Incorporated

• Medtronic, Plc.

• Edwards Lifesciences Corporation

• Vascular Solutions, Inc.

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Highlights of the Report